ADRB2 and Alzheimer disease: Thus, activation of β2-AR has been used for the treatment of many neurodegenerative diseases, such as Alzheimer’s disease (AD) (Wu et al., 2017), Rett syndrome (Mellios et al., 2014), and Parkinson’s disease (Abdelmotilib and West, 2017).